Clinical Trials
4 trialsNCT00662597 2020-12-24
ATRACT-1
Novartis
Phase 3 Terminated
NCT00738387 2020-12-24
ATTRACT-2
Novartis
Phase 3 Terminated
NCT00674102 2020-12-09
An Open-label, Phase I Trial of Intravenous ASA404 Administered in Combination With Paclitaxel and Carboplatin in Japanese Patients With Non-Small Cell Lung Cancer (NSCLC)
Novartis
Phase 1 Completed
NCT00832494 2009-01-30
Phase II Study of DMXAA (ASA404) in Combination With Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer
Antisoma Research
Phase 1/2 Completed